MedPath

Vitafol-OB Plus DHA

Vitafol -OB+DHA

Approved
Approval ID

a0e273e2-0876-4830-a903-282085be7f32

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 31, 2022

Manufacturers
FDA

Exeltis USA, Inc

DUNS: 071170534

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Vitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, Copper, and Doconexent

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0642-0076
Product Classification
G
Generic Name
Vitamin A, Ascorbic Acid, Vitamin D, .Alpha.-Tocopherol, Thiamine Mononitrate, Riboflavin, Niacin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium, Iron, Magnesium, Zinc, Copper, and Doconexent
Product Specifications
Effective DateDecember 31, 2022
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vitafol-OB Plus DHA - FDA Drug Approval Details